Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
about
The Potential for Misuse and Abuse of Medications in ADHD: A ReviewNeuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapsesImpulsive delayed reward discounting as a genetically-influenced target for drug abuse prevention: a critical evaluationReducing substance use during adolescence: a translational framework for preventionTargeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersA computational psychiatry approach identifies how alpha-2A noradrenergic agonist Guanfacine affects feature-based reinforcement learning in the macaque.Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine.The neural bases of cognitive processes in gambling disorder.A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessationEconomic choices reveal probability distortion in macaque monkeysAlpha 2A adrenergic receptor agonist, guanfacine, attenuates cocaine-related impairments of inhibitory response control and working memory in animal models.Guanfacine for the treatment of cognitive disorders: a century of discoveries at YalePregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Decision making: from neuroscience to psychiatryGuanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents.Noradrenergic modulation of risk/reward decision making.Dopamine reward prediction error responses reflect marginal utility.From habits to self-regulation: how do we change?The effect of cognitive challenge on delay discounting.Noradrenergic α2A-receptor stimulation in the ventral hippocampus reduces impulsive decision-making.α2A -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine users.Inactivation of Medial Frontal Cortex Changes Risk Preference
P2860
Q22241206-AEE5789D-82DF-4BF6-BC62-5073FBDC40BBQ24619549-10B218BD-0025-4EFF-9DBA-048F87752B35Q26782950-FE0EEEE4-1811-4F72-B313-A051760B3855Q27023852-83AD916D-758E-46FF-8B62-2D3982161737Q28076907-8EA32E17-9EEA-4850-8E95-02E867F7D9A9Q28468318-D2D1127E-BBCF-42EA-B30E-E34C74D08D3DQ30415557-2D8B26E7-52AD-41D7-844F-1299110105D0Q33955187-CC0CD8C3-AEC3-4CE4-9C82-EEA448786DBDQ34454236-01A2C590-CC81-44C6-AE7A-DC1858E1514FQ35092700-4C352E90-E31D-4D7C-AF3C-AC986FC76D65Q35120282-C9312FAB-7438-47BF-B68E-F3A24A7168B5Q35855475-7ED3280E-AFD9-420E-8DF6-9B9BD2EE7E3AQ36252863-1A3AF776-65C1-4EC5-B4F8-96AB7C467A51Q36446854-81A8C24E-6522-48B4-AB70-59A111238263Q36897293-321D58E2-3CE8-411A-ABFB-D9E780FA4986Q38225962-092279C3-172B-4C46-BBF6-95AA199E2866Q41243157-D0B71101-5606-4167-88D9-CA05733E1C31Q43000026-697BCE09-6835-49C9-849D-8930265E72AEQ43198767-054EA9B9-F935-487D-9777-7F5E8186EABBQ46054231-35C11752-DCE4-4372-8822-4B61F91EF0A7Q50719986-9D3869EE-230B-462B-96BA-1209EAB5EFCBQ52308067-2F0701C0-DF8B-4314-9937-6B37A7DFB239Q57294009-31B67706-B4AB-43CE-A167-B72E38DCD17D
P2860
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@ast
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@en
type
label
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@ast
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@en
prefLabel
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@ast
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@en
P2093
P2860
P1433
P1476
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
@en
P2093
Amy F T Arnsten
Irina Bobeica
Nao J Gamo
P2860
P2888
P304
P356
10.1007/S00213-011-2520-0
P577
2011-10-07T00:00:00Z